Advanced Search
Current and Breaking News for Professionals, Consumers and Media


Click here to learn how to advertise on this site and for ad rates.

FDA Approval Author: FDA Last Updated: Dec 28, 2007 - 11:53:31 PM



FDA Warns Consumers Not to Use Super Shangai, Strong Testis, Shangai Ultra, Shangai Ultra X, Lady Shangai, and Shangai Regular (also known as Shangai Chaojimengnan)
By FDA
Dec 28, 2007 - 11:49:11 PM

Email this article
 Printer friendly page
FDA Warns Consumers Not to Use Super Shangai, Strong Testis, Shangai Ultra, Shangai Ultra X, Lady Shangai, and Shangai Regular (also known as Shangai Chaojimengnan)

These products are illegal drugs and contain undeclared active ingredients in prescription erectile dysfunction drugs

(HealthNewsDigest.com) - The U.S. Food and Drug Administration (FDA) is advising consumers not to buy or use Super Shangai, Strong Testis, Shangai Ultra, Shangai Ultra X, Lady Shangai, and Shangai Regular, also marketed as Shangai Chaojimengnan, products.

These products, which originate in China, are being marketed for the treatment of erectile dysfunction (ED) and for sexual enhancement. Although labeled as dietary supplements, these products do not quality as dietary supplements because they contain undeclared active ingredients of FDA-approved prescription drugs for erectile dysfunction. The products are thus drugs that are illegal because they lack FDA approval.

The undeclared ingredients in these products may interact with nitrates found in some prescription drugs (such as nitroglycerin) and can lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. ED is a common problem in men with these medical conditions. Because they may have been advised against taking ED drugs, they may seek out products like these because they are marketed as “all natural” or as not containing the active ingredients in approved, prescribed ED drugs. Additionally, because the manufacturing source of the active ingredients in these products is unknown, consumers should be aware that the safety, efficacy, and purity of these ingredients can not be validated.

“Products like these put consumers at considerable risk because they contain undeclared active ingredients in FDA approved drugs that require a prescription to obtain,” said Janet Woodcock, M.D., FDA’s deputy commissioner for scientific and medical programs, chief medical officer, and acting director of the Center for Drug Evaluation and Research (CDER). “An unsuspecting consumer with underlying medical issues may buy and take these products without knowing that they can cause serious drug interactions.’’

FDA performed chemical testing of the products that revealed that Super Shangai, Strong Testis, Shangai Ultra, Shangai Ultra X, and Lady Shangai contain sildenafil, the active ingredient in Viagra, an FDA-approved drug for erectile dysfunction. Shangai Regular, also marketed as Shangai Chaojimengnan, contains an unapproved substance with a structure similar to sildenafil that may cause similar side effects and drug interactions. Neither sildenafil nor the analog of sildenafil is listed as an ingredient on the label of any of these products.

FDA advises consumers who have used any of these products to discontinue use and consult their health care providers if they have experienced any adverse events that they feel are related to the use of these products. Consumers and health care professionals can report adverse events to FDA’s MedWatch program at 800-FDA-1088 or online at www.fda.gov/medwatch/report.htm. FDA recommends that consumers should talk to their health care provider about FDA-approved treatments for erectile dysfunction. FDA may take further regulatory actions to protect consumers from these illegal products.

Consumer Inquiries: 888-INFO-FDA

The products are packaged and distributed by Shangai Distributor, Inc. of Coamo, Puerto Rico.

www.HealthNewsDigest.com

Top of Page

HealthNewsDigest.com

FDA Approval
Latest Headlines


+ FDA Acts to Avoid Shortage and Strengthen the Safety of Sucraid
+ HHS Opens Offices of the Food and Drug Administration (FDA) in China
+ FDA Warns Public of Extortion Scam by FDA Impersonators
+ FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer
+ FDA Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes
+ FDA Licenses for Marketing New Therapy for Rare Genetic Disease
+ FDA Licenses Drug to Prevent Joint Damage in Children with Hemophilia A
+ FDA Launches Food Defense Awareness Training Kit for Employees in the Food Industry
+ FDA Issues Interim Safety and Risk Assessment of Melamine and Melamine-related Compounds in Food
+ FDA Clears New CDC Test to Detect Human Influenza



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions